Further, reference is made to the Company's announcement on 29 April 2026 regarding the Company's board of directors' resolution to issue 100,000 shares to a consultant under a consultancy agreement with the Company ("Consultant Shares").

The share capital increases pertaining to Tranche 1 and the Consultant Shares, has duly been registered in the Norwegian Register of Business Enterprises. Following the share capital increases, the Company's share capital is NOK 71,513,159 divided into 71,513,159 shares, each with a nominal value of NOK 1 and each carrying one vote at the Company's general meeting.

Listing of the new shares pertaining to Tranche 1 in excess of 5,589,059 new shares, constituting 812,137 shares, requires approval and publication of a listing prospectus as approved by the Norwegian Financial Supervisory Authority. Such excess new shares pertaining to Tranche 1 have been issued on a separate, unlisted ISIN and will only become tradable on Euronext Oslo Børs following approval and publication of the prospectus, expected during Q2 2026.

For more information, please contact:
Anders Storbråten, CEO and CFO
Tel: +47 416 38 582
E-mail: ir@idexbiometrics.com

ABOUT IDEX BIOMETRICS ASA
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

The disclosures set out in this announcement are subject to the disclosure requirement pursuant to section 5-12 of the Norwegian Securities Trading Act.